Guidance for Consumers, Providers, and Payers
When actress Angelina Jolie revealed that she had undergone a double mastectomy because she tested positive for the rare hereditary BRCA1 gene—which, along with BRCA2, increases a woman’s chances of developing breast and ovarian cancer—many women probably began worrying about their own susceptibility to the gene mutation.
As a public service, ECRI Institute is offering free access to evidence-based reports and a special consumer guide to increase understanding of the BRCA gene mutation and the implications for testing and treatment.
Please click the relevant button to download the reports and access other links.
About ECRI Institute
a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes are best to enable improved patient care. As pioneers in this science for 45 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines
ensure objectivity. ECRI Institute is designated an Evidence-based Practice Center
by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services.